Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
BridgeBio Pharma (BBIO)
- 74.590
- -0.930-1.23%
Close Apr 10 15:59 ET
- 74.590
- 0.0000.00%
Post 18:36 ET
14.46BMarket Cap-19.73P/E (TTM)
75.850High74.260Low1.08MVolume75.850Open75.520Prev Close80.31MTurnover0.67%Turnover RatioLossP/E (Static)193.86MShares84.94052wk High-6.93P/B11.99BFloat Cap31.77052wk Low--Dividend TTM160.72MShs Float84.940Historical High--Div Yield TTM2.11%Range %4.980Historical Low74.640Avg Price1Lot Size
BridgeBio Pharma (BBIO) Key Financial Indicators
BBIO Earnings per Share (EPS)
According to the latest financial report of BridgeBio Pharma, the latest earnings per share (TTM) for the company is -1.00. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
BBIO Free Cash Flow (FCF)
Interested in knowing about BridgeBio Pharma's free cash flow? The latest report shows it as -56.45M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
BBIO Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of BridgeBio Pharma shows that the company's current ratio is 2.77, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
BBIO Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of BridgeBio Pharma, the quick ratio is 2.52, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
BBIO Return on Equity (ROE)
Want to learn more about the financial health of BridgeBio Pharma? The latest ROE figure is -108.26%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
BBIO Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of BridgeBio Pharma, the total asset return on investment (ROA) is -19.94%.
Currency: USD
Quarterly
Loading...
BBIO Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check BridgeBio Pharma's latest financial report to see how their gross margin is doing - currently at 94.74%.
Currency: USD
Quarterly
Loading...
BBIO Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of BridgeBio Pharma, the net profit margin is -126.24%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement,
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm